Company intelligence / Profile preview

Aurora Europe

Berlin, Germany

Ownership: Private
Employees: ~260
Development stage: Other

Overview

Aurora Europe is the leading importer and distributor of EU-GMP pharmaceutical grade medical cannabis in continental Europe, with commercial sales in Germany, the UK, France, Poland, Italy, and other EU markets. Aurora’s clinical activity includes partnerships with local healthcare and pilot programs; their products are used for treating chronic pain, spasticity, and other indications. Aurora Europe holds important government supply contracts including the French pilot program and nationwide supply contracts in Italy and Luxembourg.[5][6]

Therapeutic areas: OncologyGastroenterologyNeurology
Modalities: Plant-derived medicineSmall molecule
Industry: Biotech

Partnerships

Ethypharm (France government pilot supply)Wholesale/distribution partners in Germany, Poland, UK, and other EU countries

Beyond the preview

Go deeper on Aurora Europe.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aurora Europe.

Explore the full profile